Kemp MM - Search Results

1

Oversulfated chondroitin sulfate: impact of a heparin impurity, associated with adverse clinical events, on low-molecular-weight heparin preparation.

Zhang Z, Weïwer M, Li B, Kemp MM, Daman TH, Linhardt RJ. Zhang Z, et al. Among authors: kemp mm. J Med Chem. 2008 Sep 25;51(18):5498-501. doi: 10.1021/jm800785t. J Med Chem. 2008. PMID: 18754653 Free PMC article.

2

Mosquito heparan sulfate and its potential role in malaria infection and transmission.

Sinnis P, Coppi A, Toida T, Toyoda H, Kinoshita-Toyoda A, Xie J, Kemp MM, Linhardt RJ. Sinnis P, et al. Among authors: kemp mm. J Biol Chem. 2007 Aug 31;282(35):25376-84. doi: 10.1074/jbc.M704698200. Epub 2007 Jun 27. J Biol Chem. 2007. PMID: 17597060 Free PMC article.

3

Liquid chromatography-mass spectrometry to study chondroitin lyase action pattern.

Zhang Z, Park Y, Kemp MM, Zhao W, Im AR, Shaya D, Cygler M, Kim YS, Linhardt RJ. Zhang Z, et al. Among authors: kemp mm. Anal Biochem. 2009 Feb 1;385(1):57-64. doi: 10.1016/j.ab.2008.10.014. Epub 2008 Oct 17. Anal Biochem. 2009. PMID: 18992215 Free PMC article.

4

Heparin-based nanoparticles.

Kemp MM, Linhardt RJ. Kemp MM, et al. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010 Jan-Feb;2(1):77-87. doi: 10.1002/wnan.68. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010. PMID: 20049832 Review.

5

Synthesis and Biological Evaluation of Non-Hydrolizable 1,2,3-Triazole Linked Sialic Acid Derivatives as Neuraminidase Inhibitors.

Weïwer M, Chen CC, Kemp MM, Linhardt RJ. Weïwer M, et al. Among authors: kemp mm. European J Org Chem. 2009 Jun;2009(16):10.1002/ejoc.200900117. doi: 10.1002/ejoc.200900117. European J Org Chem. 2009. PMID: 24223493 Free PMC article.

6

Affinity, kinetic, and structural study of the interaction of 3-O-sulfotransferase isoform 1 with heparan sulfate.

Muñoz E, Xu D, Kemp M, Zhang F, Liu J, Linhardt RJ. Muñoz E, et al. Biochemistry. 2006 Apr 25;45(16):5122-8. doi: 10.1021/bi052403n. Biochemistry. 2006. PMID: 16618101 Free PMC article.

7

Synthesis of gold and silver nanoparticles stabilized with glycosaminoglycans having distinctive biological activities.

Kemp MM, Kumar A, Mousa S, Park TJ, Ajayan P, Kubotera N, Mousa SA, Linhardt RJ. Kemp MM, et al. Biomacromolecules. 2009 Mar 9;10(3):589-95. doi: 10.1021/bm801266t. Biomacromolecules. 2009. PMID: 19226107 Free PMC article.

8

Hyaluronan- and heparin-reduced silver nanoparticles with antimicrobial properties.

Kemp MM, Kumar A, Clement D, Ajayan P, Mousa S, Linhardt RJ. Kemp MM, et al. Nanomedicine (Lond). 2009 Jun;4(4):421-9. doi: 10.2217/nnm.09.24. Nanomedicine (Lond). 2009. PMID: 19505245 Free PMC article.

9

Unbiased binding assays for discovering small-molecule probes and drugs.

Kemp MM, Weïwer M, Koehler AN. Kemp MM, et al. Bioorg Med Chem. 2012 Mar 15;20(6):1979-89. doi: 10.1016/j.bmc.2011.11.071. Epub 2011 Dec 24. Bioorg Med Chem. 2012. PMID: 22230199 Review.

10

Enzymatic synthesis of heparin related polysaccharides on sensor chips: rapid screening of heparin-protein interactions.

Muñoz E, Xu D, Avci F, Kemp M, Liu J, Linhardt RJ. Muñoz E, et al. Biochem Biophys Res Commun. 2006 Jan 13;339(2):597-602. doi: 10.1016/j.bbrc.2005.11.051. Epub 2005 Nov 17. Biochem Biophys Res Commun. 2006. PMID: 16310167 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters